Cargando…
Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data
BACKGROUND: Genome sequencing and bioinformatics have provided the full hypothetical proteome of many pathogenic organisms. Advances in microarray and mass spectrometry have also yielded large output datasets of possible target proteins/genes. However, the challenge remains to identify new targets f...
Autores principales: | Toomey, David, Hoppe, Heinrich C., Brennan, Marian P., Nolan, Kevin B., Chubb, Anthony J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704375/ https://www.ncbi.nlm.nih.gov/pubmed/19593435 http://dx.doi.org/10.1371/journal.pone.0006195 |
Ejemplares similares
-
Integrating GWAS and proteome data to identify novel drug targets for MU
por: Wu, Yadong, et al.
Publicado: (2023) -
Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay
por: Diallo, Bakary N’tji, et al.
Publicado: (2021) -
Genetic and proteomic approaches to identify cancer drug targets
por: Roti, G, et al.
Publicado: (2012) -
Proteomics and genomics: perspectives on drug and target discovery
por: Ahn, Natalie G, et al.
Publicado: (2008) -
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
por: Mazidi, Mohsen, et al.
Publicado: (2023)